Advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloids
Benzylisoquinoline alkaloids (BIAs) are a prominent class of plant metabolites with significant pharmaceutical and industrial significance that have garnered substantial attention from researchers worldwide. BIAs exhibit several pharmacological activities and have been used extensively. Examples inc...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Plant Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpls.2025.1548471/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832582038618636288 |
---|---|
author | Wanli Zhao Jihua Liu Yu Chen |
author_facet | Wanli Zhao Jihua Liu Yu Chen |
author_sort | Wanli Zhao |
collection | DOAJ |
description | Benzylisoquinoline alkaloids (BIAs) are a prominent class of plant metabolites with significant pharmaceutical and industrial significance that have garnered substantial attention from researchers worldwide. BIAs exhibit several pharmacological activities and have been used extensively. Examples include analgesics such as morphine, tetrahydropalmatine, antimicrobials such as berberine, and antineoplastic agents including cepharanthine. Most BIAs are derived and isolated from medicinal plants; however, these plants are predominantly wild resources that are scarce. Their high environmental impact, slow growth rate, scarcity of resources, and expensive direct extraction costs pose a significant challenge. Certain BIAs are present in trace amounts in medicinal plants; moreover, they have complex chemical structures and unstable properties. Designing chemical synthesis routes and processes is challenging. Thus, a major obstacle in developing and utilizing these natural products in the pharmaceutical industry lies in their low abundance in nature. Consequently, the limited supply of these molecules fails to meet high research and market demands. In recent years, biosynthesis approaches have emerged as a novel and efficient method to obtain BIAs. In this review, recent progress in the field of enzymes related to the elucidation of biosynthetic pathways and the biosynthesis of BIAs are discussed, and future perspectives for designing viable strategies for their targeted manipulation are presented. |
format | Article |
id | doaj-art-905613933e7f40d8972fcfaa3f36f8a3 |
institution | Kabale University |
issn | 1664-462X |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Plant Science |
spelling | doaj-art-905613933e7f40d8972fcfaa3f36f8a32025-01-30T06:23:03ZengFrontiers Media S.A.Frontiers in Plant Science1664-462X2025-01-011610.3389/fpls.2025.15484711548471Advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloidsWanli Zhao0Jihua Liu1Yu Chen2Jiangsu Key Laboratory for the Research and Utilization of Plant Resources, Jiangsu Province Engineering Research Center of Eco-cultivation and High-value Utilization of Chinese Medicinal Materials, Institute of Botany, Jiangsu Province and Chinese Academy of Sciences (Nanjing Botanical Garden Mem. Sun Yat-Sen), Nanjing, ChinaJiangsu Key Laboratory of Traditional Chinese Medicine. (TCM) Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, ChinaJiangsu Key Laboratory for the Research and Utilization of Plant Resources, Jiangsu Province Engineering Research Center of Eco-cultivation and High-value Utilization of Chinese Medicinal Materials, Institute of Botany, Jiangsu Province and Chinese Academy of Sciences (Nanjing Botanical Garden Mem. Sun Yat-Sen), Nanjing, ChinaBenzylisoquinoline alkaloids (BIAs) are a prominent class of plant metabolites with significant pharmaceutical and industrial significance that have garnered substantial attention from researchers worldwide. BIAs exhibit several pharmacological activities and have been used extensively. Examples include analgesics such as morphine, tetrahydropalmatine, antimicrobials such as berberine, and antineoplastic agents including cepharanthine. Most BIAs are derived and isolated from medicinal plants; however, these plants are predominantly wild resources that are scarce. Their high environmental impact, slow growth rate, scarcity of resources, and expensive direct extraction costs pose a significant challenge. Certain BIAs are present in trace amounts in medicinal plants; moreover, they have complex chemical structures and unstable properties. Designing chemical synthesis routes and processes is challenging. Thus, a major obstacle in developing and utilizing these natural products in the pharmaceutical industry lies in their low abundance in nature. Consequently, the limited supply of these molecules fails to meet high research and market demands. In recent years, biosynthesis approaches have emerged as a novel and efficient method to obtain BIAs. In this review, recent progress in the field of enzymes related to the elucidation of biosynthetic pathways and the biosynthesis of BIAs are discussed, and future perspectives for designing viable strategies for their targeted manipulation are presented.https://www.frontiersin.org/articles/10.3389/fpls.2025.1548471/fullbenzylisoquinoline alkaloidsbiosynthesissecondary metabolitebiosynthetic pathwayberberine bridge enzymecytochrome P450 |
spellingShingle | Wanli Zhao Jihua Liu Yu Chen Advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloids Frontiers in Plant Science benzylisoquinoline alkaloids biosynthesis secondary metabolite biosynthetic pathway berberine bridge enzyme cytochrome P450 |
title | Advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloids |
title_full | Advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloids |
title_fullStr | Advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloids |
title_full_unstemmed | Advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloids |
title_short | Advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloids |
title_sort | advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloids |
topic | benzylisoquinoline alkaloids biosynthesis secondary metabolite biosynthetic pathway berberine bridge enzyme cytochrome P450 |
url | https://www.frontiersin.org/articles/10.3389/fpls.2025.1548471/full |
work_keys_str_mv | AT wanlizhao advancesinthebiosynthesisofnaturallyoccurringbenzylisoquinolinealkaloids AT jihualiu advancesinthebiosynthesisofnaturallyoccurringbenzylisoquinolinealkaloids AT yuchen advancesinthebiosynthesisofnaturallyoccurringbenzylisoquinolinealkaloids |